Clinical Trial Update: BARIcitinib Cognitive Emotional and Neural signaTuRE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for bari citinib in rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED